The AstraZeneca COVID vaccine is now available to Australians over 50. Here's what you need to know before you roll up your sleeve.
The COVID-19 vaccination programme requires stringent data collection and transparency.
At the current vaccination pace it will take over a decade for South Africa to reach herd immunity, with many lives lost along the way.
There are tangible things we can do now to help people understand the benefits and possible risks of COVID-19 vaccination.
Although most border workers are now vaccinated, regular testing remains essential to guard against the risk of a major outbreak in the community.
The Morrison government's decision to drop vaccination targets goes against decades of research and evidence on the importance of goal-setting.
Both the AstraZeneca and Johnson & Johnson vaccines are now being investigated for links to rare blood disorders.
A vaccine expert breaks down everything you need to know about the Novavax vaccine.
The challenge now is to address the understandable concerns and prevent them from contaminating the broader public dialogue on COVID-19 vaccination.
We'll need mass vaccination hubs and expanded GP vaccination clinics to deliver jabs to millions of Australians.
This shift in focus away from AstraZeneca to the Pfizer vaccine has serious impacts on the timing of the rollout and public confidence in the AstraZeneca vaccine.
Our well-meaning efforts to use images to help demystify the vaccination process or share our pride in getting a COVID vaccine can backfire.
All vaccines and medications come with risks. But the risks of delaying vaccination are far higher.
We need to stop relying on small GP clinics and urgently move towards using mass vaccination hubs like stadiums, schools and parks.
These mistakes have been mainly caused by our leaders giving priority to a good political story over good policy.
The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
At first glance, Australia looks to be tracking poorly compared to the rest of the world. However, context is really important here.
Exports of the vaccine continue to be a point of contention between the EU and UK, while newly released US trial results are quickly amended.
Pausing COVID-19 vaccine rollouts can backfire. There are better ways to manage safety issues while they're being investigated.
This group has long suffered much higher death rates than the general population due to a poor standard of basic healthcare.